Skip to main content
Clinical Trials/NCT06359457
NCT06359457
Completed
Not Applicable

Correlation Between Serum Progesterone Level And Menstrual Symptoms In Young Females With Primary Dysmenorrhea

Cairo University1 site in 1 country100 target enrollmentMay 5, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Primary Dysmenorrhea
Sponsor
Cairo University
Enrollment
100
Locations
1
Primary Endpoint
Serum progesterone level
Status
Completed
Last Updated
last year

Overview

Brief Summary

This study will be conducted to determine the correlation between the levels of serum progesterone and Menstrual Symptoms In Young Females with primary dysmenorrhea.

Detailed Description

One hundred adult females with primary dysmenorrhea will participate in this study. They will be recruited from the Gynaecological outpatient clinic, Kasr El Ainy University Hospital, Cairo, Egypt Many studies reported that primary dysmenorrhea was the result of increased prostaglandin, especially prostaglandin F2α (PGF2α) and prostaglandin E2 (PGE2) which produced the effect through the cyclooxygenase pathway, and further led to uterine ischemia hypoxia. Nevertheless the relationship between the serum progesterone level and menstrual symptoms was not completely clear. Hence, this study will investigate the association between the serum progesterone level and menstrual symptoms in young females with primaryf dysmenorrhea.

Registry
clinicaltrials.gov
Start Date
May 5, 2024
End Date
December 31, 2024
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mennaallah Yousef Mohamed Nasreldien

Lecturer of physical therapy for women's health

Cairo University

Eligibility Criteria

Inclusion Criteria

  • One hundreds adult females were suffered from primary dysmenorrhea.
  • Their age was ranged from 17 to 24 years.
  • Their body mass index was ranged from 20 to 25 kg/m2.

Exclusion Criteria

  • Any participant will be excluded from the study if they have:
  • Irregulars or infrequent menstrual cycles.
  • Pacemaker, Myasthenia gravis, hyperthyroidism, active tuberculosis and psychosis.
  • Pelvic pathology.

Outcomes

Primary Outcomes

Serum progesterone level

Time Frame: 1 month

Blood samples will be taken by physician for each girl, and will send to laboratory center to measure the progesterone level in the blood. The normal serum progesterone level at 21st day is 4-20 ng

Pain intensity

Time Frame: 1 month

It will be measured by Visual analogue scale. It is 10 cm line with values ranging from 0 to 10. 0 indicates no pain nd 10 indicates the worst pain.

Physical and psychological menstrual symptoms

Time Frame: 1 month

It will be measured by menstrual symptoms questionnaire. It is 25 items split into two categories which used to assess the physical and psychological symptoms associated with dysmenorrhea. The score on each item ranged from 1 (never) to 5 (always) with a higher composite score indicating more symptoms

Correlation between serum progesterone level and pain

Time Frame: 1 month

The correlation between serum progesterone level and pain intensity measured by the VAS will be conducted

Correlation between serum progesterone level and menstrual symptoms

Time Frame: 1 month

The correlation between serum progesterone level and menstrual symptoms measured by the menstrual symptom questionnaire will be conducted

Study Sites (1)

Loading locations...

Similar Trials